AxioMed
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
350 Main St Fl 2, Malden, Massachusetts,...Phone Number
(978) 232-3990Website
www.axiomed.comRevenue
$5 MillionIndustry
About AxioMed
AxioMed Org Chart
Is AxioMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if AxioMed has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on AxioMed recently announced quarterly report
AxioMed, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if AxioMed is spiking on competitors!
Product Launch: Get notified when AxioMed launches new products
Congratulate Masked Content for being promoted to Masked Content at AxioMed
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once AxioMed has new funding data
Click to see if AxioMed had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to AxioMed
Compare insights from companies similar to AxioMed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AxioMed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AxioMed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AxioMed.
AxioMed financials insights
Gather financial insights about AxioMed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$2.8M
Series B
$18M
Series D
$15M
Debt
$1.1M
Private Equity
$1M
AxioMed Tech Stack
A closer look at the technologies used by AxioMed
Most Recent Scoops
AxioMed News & Media
Lessons In Visionary Investments: Dr. Kingsley Chin's Journey with AxioMed Mirrors Elon Musk's Bold Bet on Tesla
Dr. Kingsley R. Chin, founder of KIC Ventures, compares his investment in AxioMed's viscoelastic disc technology to Elon Musk's early stake in Tesla—a bold commitment that has the potential to redefine its industry. Dr. Chin envisions AxioMed achieving a $5 billion valuation, which would...Dr. Kingsley R Chin Granted Patent To Add Wireless Sensor To AxioMed’s Total Disc Replacement To Target $23.50B Smart Medical Device Market
Dr. Kingsley R Chin and engineers granted wireless sensor patent for the AxioMed viscoelastic total disc replacement which they plan to leverage to gain market share in the growing smart medical device market estimated to be valued at $23.50 billion. (PRWeb September 15, 2022) Read the full story at https://www.prweb.com/releases/dr_kingsley_r_chin_granted_patent_to_add_wireless_sensor_to_axiomeds_total_disc_replacement_to_target_23_50b_smart_medical_device_market/prweb18898589.htmAxioMed LLC Submits Final Module III to the FDA Becoming the First and Only Lumbar Viscoelastic Total Disc Replacement Company to Complete a USA IDE Clinical Trial
On August 8, 2022, AxioMed LLC submitted to the FDA all the required documents for Module III. This is the final Module containing all the data tables comparing AxioMed to the Prodisc as the control. The final step for AxioMed to get USA market approval will be an FDA site inspection of the cleanroom manufacturing facilities in Massachusetts. (PRWeb August 08, 2022) Read the full story at https://www.prweb.com/releases/axiomed_llc_submits_final_module_iii_to_the_fda_becoming_the_first_and_only_lAxioMed Announces Progress with Completing Module I-III Lumbar FDA Submission of The First Lumbar Viscoelastic Disc Replacement to Complete a US IDE Clinical Study
AxioMed presses forward on its FDA submission of documents needed to complete the last Module III of its FDA application needed to get approval to market its viscoelastic lumbar disc replacement in the USA. AxioMed is actively engaged with the FDA to complete responses to all their queries from its previously submitted Module I and II while also completing its final clinical data analyses required for the last Module III submission targeted on or before
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AxioMed
AxioMed specializes in advanced spinal disc replacement technologies, particularly their proprietary one-piece viscoelastic discs designed to restore normal spine motion and provide long-lasting support. Founded in 2001 by surgeons and engineers, the company has developed several innovative products, including the Freedom Cervical and Lumbar Discs,... Read More